APA (7th ed.) Citation

Hu, Z., Zheng, Y., Zheng, J., Wang, Y., Liao, J., Liu, Z., . . . Cui, H. (2024). Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis. Cancer Medicine, 13(11), 1. https://doi.org/10.1002/cam4.7241

Chicago Style (17th ed.) Citation

Hu, Zixin, Yumin Zheng, Jiabin Zheng, Yan Wang, Jiangquan Liao, Zhening Liu, Jia Li, and Huijuan Cui. "Effect of Body Mass Index and Cholesterol‐rich Apolipoprotein‐B‐containing Lipoproteins on Clinical Outcome in NSCLC Patients Treated with Immune Checkpoint Inhibitors‐based Therapy: A Retrospective Analysis." Cancer Medicine 13, no. 11 (2024): 1. https://doi.org/10.1002/cam4.7241.

MLA (9th ed.) Citation

Hu, Zixin, et al. "Effect of Body Mass Index and Cholesterol‐rich Apolipoprotein‐B‐containing Lipoproteins on Clinical Outcome in NSCLC Patients Treated with Immune Checkpoint Inhibitors‐based Therapy: A Retrospective Analysis." Cancer Medicine, vol. 13, no. 11, 2024, p. 1, https://doi.org/10.1002/cam4.7241.